These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Treatment development program: the National Alopecia Areata Foundation's initiative for achieving safe and effective therapies. Gelula RL J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S46-7. PubMed ID: 24326553 [TBL] [Abstract][Full Text] [Related]
3. Development of Uniform Protocol for Alopecia Areata Clinical Trials. Solomon JA J Investig Dermatol Symp Proc; 2015 Nov; 17(2):63-6. PubMed ID: 26551952 [TBL] [Abstract][Full Text] [Related]
4. From Targets to Treatments: Bridging Autoimmune Research to Advance Understanding of Alopecia Areata. Kranz D; Ellison A; Frelinger JA; Mackay-Wiggan J; Norris DA J Investig Dermatol Symp Proc; 2015 Nov; 17(2):1-5. PubMed ID: 26551934 [TBL] [Abstract][Full Text] [Related]
5. Oral administration of cyclosporin A in patients with severe alopecia areata. Rallis E; Nasiopoulou A; Kouskoukis C; Roussaki-Schulze A; Koumantaki E; Karpouzis A; Arvanitis A Int J Tissue React; 2005; 27(3):107-10. PubMed ID: 16372476 [TBL] [Abstract][Full Text] [Related]
6. Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata Foundation. Olsen EA; Hordinsky MK; Price VH; Roberts JL; Shapiro J; Canfield D; Duvic M; King LE; McMichael AJ; Randall VA; Turner ML; Sperling L; Whiting DA; Norris D; J Am Acad Dermatol; 2004 Sep; 51(3):440-7. PubMed ID: 15337988 [No Abstract] [Full Text] [Related]
7. Overview of AA and Research Progress: What Have We Learned and Where Are We Headed? Norris DA J Investig Dermatol Symp Proc; 2015 Nov; 17(2):6-8. PubMed ID: 26551935 [TBL] [Abstract][Full Text] [Related]
8. Introduction to innovations in the immunology and clinical science of alopecia areata. Kalabokes VD; Bergfeld WF; Christiano AM J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S1-4. PubMed ID: 24326539 [TBL] [Abstract][Full Text] [Related]
9. DNCB use in treating extensive alopecia areata. Strick RA J Investig Dermatol Symp Proc; 2013 Dec; 16(1):S45. PubMed ID: 24326552 [TBL] [Abstract][Full Text] [Related]
10. Systemic treatment for alopecia areata. Otberg N Dermatol Ther; 2011; 24(3):320-5. PubMed ID: 21689241 [TBL] [Abstract][Full Text] [Related]
11. Industry Perspective on Alopecia Areata. Wagner AT J Investig Dermatol Symp Proc; 2015 Nov; 17(2):67-9. PubMed ID: 26551953 [TBL] [Abstract][Full Text] [Related]
12. Investigative guidelines for alopecia areata. Olsen EA Dermatol Ther; 2011; 24(3):311-9. PubMed ID: 21689240 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of anthralin in the treatment of alopecia areata. Fiedler-Weiss VC; Buys CM Arch Dermatol; 1987 Nov; 123(11):1491-3. PubMed ID: 3314718 [TBL] [Abstract][Full Text] [Related]
14. [High-dose intravenous corticosteroid pulse therapy in alopecia areata: own experience compared with the literature]. Kälin U; Hunziker T J Dtsch Dermatol Ges; 2008 Oct; 6(10):895-6. PubMed ID: 18992030 [No Abstract] [Full Text] [Related]